Welcome to our dedicated page for MINIMED GROUP SEC filings (Ticker: MMED), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MINIMED GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MINIMED GROUP's regulatory disclosures and financial reporting.
MiniMed Group, Inc. director Glenn A. Eisenberg filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider of the company. The filing does not list any equity transactions or existing derivative positions.
MiniMed Group, Inc. director Kevin E. Lofton filed an initial Form 3 reporting his status as an insider of the company. The filing does not list any common stock or derivative holdings and shows no reported purchases, sales, exercises, gifts, or other transactions.
MiniMed Group, Inc. officer Gyurci John filed an initial Form 3 reporting his status as a company officer. This is a baseline ownership filing required when someone becomes subject to insider reporting rules. The filing does not report any transactions or derivatives positions in MiniMed Group stock.
MiniMed Group, Inc. filed an initial insider ownership report for officer Chandrasena Gillian on Form 3. The data provided shows no reported transactions, no buy or sell activity, and no derivative positions, indicating this filing is primarily a baseline disclosure of status as an officer.
MiniMed Group, Inc. officer Wills Courtney Nelson filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing shows no reportable holdings or transactions in MiniMed Group securities in the data provided.
MiniMed Group, Inc. executive Dianaty Ali filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing does not report any equity transactions or any current holdings of MiniMed Group securities, and serves mainly as a baseline disclosure of insider status.
MiniMed Group, Inc. executive Chad Spooner, who serves as EVP and Chief Financial Officer, filed an initial statement of beneficial ownership on Form 3. The filing does not list any buy, sell, or other insider transactions and shows no derivative positions or holdings entries.
MiniMed Group, Inc. director and Chief Executive Officer Dallara Que filed an initial ownership report on Form 3. This filing establishes Que’s status as an insider of the company but does not list any transactions or specific share holdings.
MiniMed Group, Inc. President Eso Christopher filed an initial ownership report on Form 3. This filing identifies him as an officer of the company but does not list any specific share holdings or transactions. It is a routine SEC disclosure required when someone becomes an insider.
MiniMed Group, Inc. director Brian Sandstrom filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing lists him as a director of MiniMed Group but does not report any insider stock transactions.